When was Palisade Bio founded?

Palisade Bio was founded in 2005 and raised its 1st funding round 12 years after it was founded.

Where is Palisade Bio located?

Palisade Bio is headquartered in Carlsbad, United States.

How many employees does Palisade Bio have?

As of Aug 31, 2026, the latest employee count at Palisade Bio is 25.

Is Palisade Bio a funded company?

Palisade Bio is a funded company, having raised an undisclosed amount across 6 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Aug 01, 2017.

When was the latest funding round of Palisade Bio?

Palisade Bio's latest funding was a $***** Post IPO round on Jan 07, 2026, with participation from 1 investor.

What is the annual revenue of Palisade Bio?

Annual revenue of Palisade Bio is less than $1M as on Dec 31, 2023

Where does Palisade Bio rank among its competitors?

Palisade Bio ranks 1st amongst 7 active competitors, none of which are funded.

Who are the top competitors of Palisade Bio?

Palisade Bio's top competitors include CJ HealthCare, Nucliqbio and My Health. Among them, Palisade Bio secured the most recent funding round in January, 2026.

Palisade Bio - 2026 Company Profile, Team, Funding, Competitors & Financials

Palisade Bio is a public company based in Carlsbad (United States), founded in 2005. It operates as a Developer of therapeutics for gastrointestinal complications. Palisade Bio has raised an undisclosed amount in funding. The company has 7 active competitors, including 2 that have exited. Its top competitors include companies like CJ HealthCare, Nucliqbio and My Health.

Company Details

Developer of therapeutics for gastrointestinal complications. The company's lead candidate GT-2108 is a microbiota-activated PDE4 inhibitor prodrug for the treatment of moderate-to-severe ulcerative colitis. Other drug is GT-1908 for fibrostenotic crohn’s disease.

Website: palisadebio.com
Social
Email ID: *****@palisadebio.com
Phone Number: +1 **********

Key Metrics

Founded Year

2005

Location

Carlsbad, United States

Stage

Public

Latest Funding Round

Post IPO, Jan 07, 2026, $*****

Investors

Crohn's & Colitis Foundation & 3 more

Ranked

1^st among 7 active competitors

Annual Revenue

$0 - $1M as on Dec 31, 2023

Employee Count

25 as on Aug 31, 2026

Similar Companies

CJ HealthCare & 6 more

Exit Details

Public

View Palisade Bio's full profile

Palisade Bio is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
SENECA BIOPHARMA, INC. CIN: 1357459 , United States, Active		$0 - $1M (As on Dec 31, 2023)	12 (As on Dec 31, 2022)	-

Palisade Bio got listed on Dec 16, 2020.

Click here to take a look at Palisade Bio's IPO in detail

Palisade Bio has raised funding over 6 rounds. Its first funding round was on Aug 01, 2017. Its latest funding round was a Post IPO round on Jan 07, 2026 for $*****. 1 investor participated in its latest round. Palisade Bio has 4 institutional investors.

Here is the list of recent funding rounds of Palisade Bio:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 07, 2026	5066656	Post IPO	5608448	9281994	8486783	2795526
May 06, 2024	4410185	Post IPO	2337577	1666897	1091456	7028089
Dec 07, 2022	3018887	Post IPO	4974977	8711056	1017760	5951427

Access funding benchmarks and valuations. Sign up today!

View details of Palisade Bio's funding rounds and investors

Palisade Bio's employee count trend

Palisade Bio has 25 employees as of Aug 26. Here is Palisade Bio's employee count trend over the years:

Uncover Palisade Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Palisade Bio include CJ HealthCare, Nucliqbio and My Health. Here is the list of Top 10 competitors of Palisade Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Palisade Bio 2005, Carlsbad (United States), Public	Developer of therapeutics for gastrointestinal complications	-	Crohn's & Colitis Foundation, Business Innovation Network ... & 2 others	47/100
2nd	CJ HealthCare 1986, Seoul (South Korea), Acquired	Developer of therapies for treating gastrointestinal disorders	-	Mirae Asset Global Investments	32/100
3rd	Nucliqbio 2019, St. John's (Canada), Funding Raised	Developer of drugs for the treatment of gut health by using metagenomics	-	Canadian Space Agency, Genesis	30/100
4th	My Health 2017, Hasselt (Belgium), Unfunded	Developer of microbial probiotic strains	-	-	26/100
5th	Amyra 2013, Basel (Switzerland), Unfunded	Developer of therapeutic solutions for gluten-related disorders	-	-	26/100
6th	Mutaflor Germany, Unfunded	Provider of pharmaceutical products addressing bowel issues like constipation and diarrhea	-	-	16/100
7th	Kademann-Pharma Germany, Unfunded	Manufacturer of pharmaceutical products focused on the gut and immune system	-	-	16/100
8th	Fiat Care Biomedical 2021, Seoul (South Korea), Deadpooled	Developer of therapeutic drugs to treat oxidant- induced injury and inflammatory diseases	-	-	15/100